Vertex recently said the product may deliver more than $100 million in revenue in the 2025 full year. But it's important to ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

All investors would love to get rich overnight. As anyone who's been in the market for a while can attest, however, that's just not how things work. Growing wealth takes time. And, the more time ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

In the latest close session, CRISPR Therapeutics AG (CRSP) was down 2.5% at $56.46. The stock's performance was behind the S&P 500's daily gain of 0.46%. On the other hand, the Dow registered a gain ...